UBS Group’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
115,139
+77,978
| +210% | +$1.06M | ﹤0.01% | 4019 |
|
|
2025
Q1 | $590K | Sell |
37,161
-11,724
| -24% | -$186K | ﹤0.01% | 4567 |
|
|
2024
Q4 | $602K | Buy |
48,885
+32,785
| +204% | +$404K | ﹤0.01% | 4574 |
|
|
2024
Q3 | $195K | Buy |
16,100
+5,313
| +49% | +$64.3K | ﹤0.01% | 4719 |
|
|
2024
Q2 | $126K | Sell |
10,787
-8,932
| -45% | -$105K | ﹤0.01% | 4876 |
|
|
2024
Q1 | $255K | Sell |
19,719
-1,881
| -9% | -$24.3K | ﹤0.01% | 4552 |
|
|
2023
Q4 | $186K | Buy |
21,600
+14,099
| +188% | +$121K | ﹤0.01% | 4639 |
|
|
2023
Q3 | $71.3K | Sell |
7,501
-505
| -6% | -$4.8K | ﹤0.01% | 4946 |
|
|
2023
Q2 | $137K | Buy |
+8,006
| New | +$137K | ﹤0.01% | 4724 |
|